Axitinib and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Axitinib (axitinib), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Keytruda, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Axitinib. It is created by eHealthMe based on reports of 3,177 people who have side effects when taking Axitinib from the FDA, and is updated regularly.

What is Axitinib?

Axitinib has active ingredients of axitinib. eHealthMe is studying from 3,179 Axitinib users. Check the latest studies of Axitinib.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

On Jul, 13, 2026

3,177 people reported to have side effects when taking Axitinib.
Among them, 13 people (0.41%) have Type 1 diabetes.

Among these 13 people:

How long have people been on Axitinib when they have Type 1 diabetes? *

What is the gender of people who have Type 1 diabetes when taking Axitinib? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Type 1 diabetes when taking Axitinib? *

What are other drugs people take besides Axitinib? *

What are other side effects people have besides Type 1 diabetes? *

Stomatitis (inflammation of mucous membrane of mouth): 2 people, 15.38%
Small Intestinal Obstruction (blockage in small intestine): 2 people, 15.38%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 15.38%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 2 people, 15.38%
Biliary Tract Infection: 2 people, 15.38%
Weakness: 1 person, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Malignant Neoplasm Progression (cancer tumour came back): 1 person, 7.69%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 7.69%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 7.69%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 8 people, 61.54%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 3 people, 23.08%
Type 2 Diabetes: 2 people, 15.38%
Renal Cancer Stage Iv (the tumour has spread to areas beyond gerota's fascia and extends into the adrenal gland on the same side of the body as the tumour, possibly to lymph nodes, but not to other parts of the body): 1 person, 7.69%
Malignant Neoplasm Of Renal Pelvis (cancer tumour of ureter): 1 person, 7.69%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 1 person, 7.69%
Alveolar Soft Part Sarcoma Metastatic (soft tissue cancer, that grows slowly and whose cell of origin is unknown-metastatic): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Axitinib and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Axitinib:

Axitinib (3,179 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,845 reports)

Browse all side effects of Axitinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,643 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on axitinib (the active ingredients of Axitinib) and Axitinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.